Caris Life Sciences and Ontada Partner to Advance Precision Oncology

Caris Life Sciences, a trailblazer in AI-powered precision medicine, has announced a groundbreaking partnership with Ontada, a leader in oncology real-world evidence and clinical education. This collaboration combines Caris’ expansive genomic database, built from over 6.5 million molecular tests, with Ontada’s real-world data representing 2.4 million cancer patient records. Together, they aim to accelerate cancer research and empower life sciences companies to innovate and deliver actionable insights for personalized cancer care.

Christine Davis, President of Ontada, highlighted the partnership's significance: "Bringing together two of the largest clinical and genomic datasets in oncology creates unparalleled opportunities for research and treatment innovation. Our shared vision is to improve patient outcomes and make precision medicine more accessible." This partnership sets the stage for a transformative approach to cancer care, ensuring faster access to personalized therapies and clinical trials while fostering a new era of collaboration between research and real-world application.